Melanoma | Oncology Today with Dr Neil Love: BRAF-Mutant Metastatic Melanoma

Research To Practice | Oncology Videos · Oct 27, 2022 · 53m

Featuring an interview with Prof Axel Hauschild, including the following topics:

Pan-tumor approval of dabrafenib/trametinib; data with adjuvant targeted therapy for melanoma (0:00)

Emerging data with encorafenib/binimetinib for Stage II melanoma; switching from dabrafenib/trametinib to encorafenib/binimetinib (5:23)

Recent data with ipilimumab/nivolumab versus dabrafenib/trametinib from the DREAMseq trial; using targeted therapy after immunotherapy (9:58)

Relationship between tumor mutational burden and response to targeted therapies and immunotherapies; PD-L1 expression and efficacy of…